Skip to main content
Erschienen in: Neurological Sciences 1/2021

28.09.2020 | Brief Communication

Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder

verfasst von: Maria Tappatà, Patrizia Riguzzi, Lilia Volpi, Luca Albini Riccioli, Roberta Pantieri, Roberto Michelucci

Erschienen in: Neurological Sciences | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

The issue of persistence of NMDAR antibodies after encephalitis is not fully elucidated and their relationship with demyelinating disorders has been suggested. A female patient showed at the age of 18 an acute neurological disorder (with psychiatric symptoms, focal seizures, orofacial dyskinesias and hypoventilation requiring ventilatory support) clinically mimicking anti-NMDAR encephalitis. At that time specific laboratory tests were not available, CSF revealed oligoclonal bands and MRI was negative. The patient had full recovery after first line immunotherapy (i.v. steroids and immunoglobulins). Fifteen years later, at the age of 33, she was hospitalized with subacute right hemiparesis and MRI disclosed multiple T2 hyperintensities in the white matter, one of them in the left midbrain showing contrast enhancement. Serum and CSF NMDAR antibodies were positive while MOG and AQP4 antibodies were negative. Intravenous methylprednisolone led to complete recovery. This case report provides evidence of a long-term persistence of NMDAR antibodies even 15 years after the encephalitis and raises the suspicion of a possible causal relationship between NMDAR antibodies and demyelinating disorders in the form of multiple sclerosis.
Literatur
1.
Zurück zum Zitat Dalmau J, Armanguè T, Planagumà J et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18:1045–1057CrossRef Dalmau J, Armanguè T, Planagumà J et al (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18:1045–1057CrossRef
2.
Zurück zum Zitat Titulaer MJ, Hoftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis [J]. Ann Neurol 75(3):411–428CrossRef Titulaer MJ, Hoftberger R, Iizuka T et al (2014) Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis [J]. Ann Neurol 75(3):411–428CrossRef
4.
Zurück zum Zitat Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, Rogemond V, Honnorat J (2012) Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol 19(2):e16–e17CrossRef Lekoubou A, Viaccoz A, Didelot A, Anastasi A, Marignier R, Ducray F, Rogemond V, Honnorat J (2012) Anti-N-methyl-D-aspartate receptor encephalitis with acute disseminated encephalomyelitis-like MRI features. Eur J Neurol 19(2):e16–e17CrossRef
6.
Zurück zum Zitat Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511CrossRef Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511CrossRef
7.
Zurück zum Zitat Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, Mccracken L, Leypoldt F et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167–177CrossRef Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, Mccracken L, Leypoldt F et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13:167–177CrossRef
8.
Zurück zum Zitat Hansen HC, Klingbeil C, Dalmau J, Li W, Weissbrich B, Wandinger KP (2013) Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 70:117–119CrossRef Hansen HC, Klingbeil C, Dalmau J, Li W, Weissbrich B, Wandinger KP (2013) Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. JAMA Neurol 70:117–119CrossRef
9.
Zurück zum Zitat Waschbisch A, Kallmunzer B, Schwab S et al (2014) Demyelinating disease and anti-NMDAR IgG antibodies: a case report. Ann Neurol 75:411–428CrossRef Waschbisch A, Kallmunzer B, Schwab S et al (2014) Demyelinating disease and anti-NMDAR IgG antibodies: a case report. Ann Neurol 75:411–428CrossRef
10.
Zurück zum Zitat Uzawa A, Mori M, Takahashi Y, Ogawa Y, Uchiyama T, Kuwabara S (2012) Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis. Clin Neurol Neurosurg 114:402–404CrossRef Uzawa A, Mori M, Takahashi Y, Ogawa Y, Uchiyama T, Kuwabara S (2012) Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis. Clin Neurol Neurosurg 114:402–404CrossRef
Metadaten
Titel
Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder
verfasst von
Maria Tappatà
Patrizia Riguzzi
Lilia Volpi
Luca Albini Riccioli
Roberta Pantieri
Roberto Michelucci
Publikationsdatum
28.09.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 1/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04729-3

Weitere Artikel der Ausgabe 1/2021

Neurological Sciences 1/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.